首页> 美国卫生研究院文献>BMJ Case Reports >Case Report: Development of an intracranial dural arteriovenous fistula after venous sinus stenting for idiopathic intracranial hypertension
【2h】

Case Report: Development of an intracranial dural arteriovenous fistula after venous sinus stenting for idiopathic intracranial hypertension

机译:病例报告:静脉窦支架置入治疗特发性颅内高压后颅内硬脑膜动静脉瘘的发展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report a case in which an intracranial dural arteriovenous fistula (DAVF) developed after endovascular treatment of a patient with idiopathic intracranial hypertension with venous sinus stenting (VSS). The pathogenesis may involve hemodynamic alterations secondary to increased poststenting venous sinus pressure, which may cause new arterial ingrowth into the fistulous sinus wall without capillary interposition. Despite administration of dual antiplatelet therapy, there may also be subclinical cortical vein thrombosis that contributed to DAVF formation. In addition to the aforementioned mechanisms, increased inflammation induced by VSS may upregulate vascular endothelial growth factor and platelet-derived growth factor expression and also promote DAVF pathogenesis. Since VSS has been used to obliterate DAVFs, DAVF formation after VSS may seem counterintuitive. Previous stents have generally been closed cell, stainless steel designs used to maximize radial compression of the fistulous sinus wall. In contrast, our patient’s stent was an open cell, self-expandable nitinol design (Protégé Everflex). Neurointerventionalists should be aware of this potential, although rare complication of DAVF formation after VSS.
机译:我们报告了一种病例,其中特发性颅内高压患者静脉窦支架置入术(VSS)的血管内治疗后颅内硬脑膜动静脉瘘(DAVF)出现。发病机制可能涉及血流动力学改变,继而引起支架后静脉窦压力升高,这可能导致新的动脉向内生长进入瘘窦壁而无毛细血管插入。尽管采用双重抗血小板治疗,但也可能存在亚临床皮层静脉血栓形成,从而导致DAVF形成。除上述机制外,VSS诱发的炎症增加可能会上调血管内皮生长因子和血小板衍生的生长因子的表达,并促进DAVF的发病机理。由于已使用VSS消除了DAVF,因此在VSS之后形成DAVF似乎违反直觉。以前的支架通常是闭孔不锈钢设计,用于最大化瘘管窦壁的径向压缩。相比之下,我们患者的支架是开孔的,可自扩张的镍钛合金设计(ProtégéEverflex)。尽管介入治疗后DAVF形成的罕见并发症很少,但神经介入专家应意识到这一潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号